FILIPPI, ANDREA RICCARDO
FILIPPI, ANDREA RICCARDO
Dipartimento di Oncologia ed Emato-Oncologia
A Glimpse Into the Future for Unresectable Stage III Non-Small Cell Lung Cancer
2023 V. Bartolomeo, F. Cortiula, L.E.L. Hendriks, D. De Ruysscher, A.R. Filippi
Rationale and Design of a Single-Arm, Phase 2, Multi-Center Study of Chemo-Immunotherapy Followed by Hypo-Fractionated RT and Maintenance Immunotherapy in Patients With Unresectable Stage III NSCLC: The DEDALUS Trial
2023 A.R. Filippi, F. Agustoni, S. Arcangeli, D. Cortinovis, A. Ferrari, D. Cicognini, J. Saddi, C. Klersy, P. Pedrazzoli, U. Malapelle, F. Grossi
Performance of an AI algorithm during the different phases of the COVID pandemics: what can we learn from the AI and vice versa
2023 M. Catalano, C. Bortolotto, G. Nicora, M.F. Achilli, A. Consonni, L. Ruongo, G. Callea, A. Lo Tito, C. Biasibetti, A. Donatelli, S. Cutti, F. Comotto, G.M. Stella, A. Corsico, S. Perlini, R. Bellazzi, R. Bruno, A. Filippi, L. Preda
The Role of Native T1 and T2 Mapping Times in Identifying PD-L1 Expression and the Histological Subtype of NSCLCs
2023 C. Bortolotto, G. Messana, A. Lo Tito, G. Stella, A. Pinto, C. Podrecca, R. Bellazzi, A. Gerbasi, F. Agustoni, F. Han, D. Nickel, D. Zacà, A.R. Filippi, O. Maria Bottinelli, L. Preda
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi
2023 M. Gotti, R. Sciarra, A. Pulsoni, F. Merli, S. Luminari, C. Zerbi, L. Trentin, A. Re, C. Rusconi, S. Viviani, A. Rossi, F. Cocito, B. Botto, E. Meli, A. Pinto, I. Dogliotti, G. Gini, B. Puccini, F. Ricci, L. Nassi, A. Fabbri, A.M. Liberati, M. Merli, A.R. Filippi, M. Bonfichi, V. Zoboli, G. Tartaglia, G. Annechini, G.M. D'Elia, I. Del Giudice, I. Alvarez, A. Visentin, S. Pravato, D. Dalceggio, C. Pagani, S. Ferrari, C. Cristinelli, T. Lazic, V.V. Ferretti, U. Ricardi, L. Arcaini
Correlation between PD-L1 Expression of Non-Small Cell Lung Cancer and Data from IVIM-DWI Acquired during Magnetic Resonance of the Thorax: Preliminary Results
2022 C. Bortolotto, G. Stella, G. Messana, A. Lo Tito, C. Podrecca, G. Nicora, R. Bellazzi, A. Gerbasi, F. Agustoni, R. Grimm, D. Zacà, A.R. Filippi, O. Maria Bottinelli, L. Preda
Preliminary report on harmonization of features extraction process using the ComBat tool in the multi-center "Blue Sky Radiomics" study on stage III unresectable NSCLC
2022 R.F. Cabini, F. Brero, A. Lancia, C. Stelitano, O. Oneta, E. Ballante, E. Puppo, M. Mariani, E. Alì, V. Bartolomeo, M. Montesano, E. Merizzoli, D. Aluia, F. Agustoni, G.M. Stella, R. Sun, L. Bianchini, E. Deutsch, S. Figini, C. Bortolotto, L. Preda, A. Lascialfari, A.R. Filippi
Recent advancement on PD-L1 expression quantification : The radiologist perspective on CT-guided FNAC
2021 S. Casale, C. Bortolotto, G.M. Stella, A.R. Filippi, S. Gitto, O.M. Bottinelli, S. Carnevale, P. Morbini, L. Preda
Low-dose radiotherapy for extranodal marginal zone B lymphoma of the lip: Case report and literature review
2021 B. Lavinia, S.S. Dario, P. Guido, G. Eva, B. Enrico, A.R. Filippi, F. Massa, R.R. Maria Grazia
Almost one year of COVID-19 pandemic : how radiotherapy centers have counteracted its impact on cancer treatment in Lombardy, Italy. CODRAL/AIRO-L study
2021 B.A. Jereczek-Fossa, M.F. Palazzi, S. Tonoli, M. Zaffaroni, G. Marvaso, G.B. Ivaldi, M. Amadori, P. Antognoni, S. Arcangeli, A. Buffoli, G. Beltramo, M. Bignardi, S. Bracelli, A. De Stefani, S. Castiglioni, G. Catalano, N. Di Muzio, A. Cerrotta, L. Fariselli, A.R. Filippi, A. Gramaglia, C. Italia, P. Massaro, S.M. Magrini, S. Nava, E. Orlandi, N. Pasinetti, E.L. Sbicego, L. Scandolaro, M. Scorsetti, C. Barbonetti, R. Tortini, R. Valdagni, V. Vavassori, M. Pepa, L.F. Cazzaniga, C.P. Soatti
In reply to Fiorino et al.: The central role of the radiation oncologist in the multidisciplinary & multiprofessional model of modern radiation therapy
2021 F. Alongi, S. Arcangeli, F. Cuccia, R.M. D'Angelillo, N.G. Di Muzio, A.R. Filippi, B.A. Jereczek-Fossa, L. Livi, S. Pergolizzi, M. Scorsetti, R. Corvo, S.M. Magrini
Development and implementation of proton therapy for hodgkin lymphoma: Challenges and perspectives
2021 P. Loap, L. De Marzi, A. Mirandola, R. Dendale, A. Iannalfi, V. Vitolo, A. Barcellini, A.R. Filippi, B.A. Jereczek-Fossa, Y. Kirova, E. Orlandi
Current situation of proton therapy for hodgkin lymphoma: From expectations to evidence
2021 P. Loap, A. Mirandola, L. De Marzi, R. Dendale, A. Iannalfi, V. Vitolo, A. Barcellini, A.R. Filippi, B.A. Jereczek-Fossa, Y. Kirova, E. Orlandi
COVID-19 safe and fully operational radiotherapy: An AIRO survey depicting the Italian landscape at the dawn of phase 2
2021 B.A. Jereczek-Fossa, M. Pepa, M. Zaffaroni, G. Marvaso, A. Bruni, M. Buglione di Monale e Bastia, G. Catalano, A.R. Filippi, P. Franco, M.A. Gambacorta, D. Genovesi, G. Iati, A. Magli, L. Marafioti, I. Meattini, A. Merlotti, M. Mignogna, D. Musio, R. Pacelli, S. Pergolizzi, V. Tombolini, M. Trovo, M.C. Leonardi, U. Ricardi, S.M. Magrini, R. Corvo, V. Donato
A real-world, multicenter, observational retrospective study of durvalumab after concomitant or sequential chemoradiation for unresectable stage III non-small cell lung cancer
2021 A. Bruni, V. Scotti, P. Borghetti, S. Vagge, S. Cozzi, E. D'Angelo, N. Giaj Levra, A. Fozza, M. Taraborrelli, G. Piperno, V. Vanoni, M. Sepulcri, M. Trovo, V. Nardone, E. Lattanzi, S. Bou Selman, F. Bertolini, D. Franceschini, F. Agustoni, B.A. Jereczek-Fossa, S.M. Magrini, L. Livi, F. Lohr, A.R. Filippi
COVID-19 Outbreak and Cancer Radiotherapy Disruption in Lombardy, Northern Italy
2020 B.A. Jereczek-Fossa, M.F. Palazzi, C.P. Soatti, L.F. Cazzaniga, G.B. Ivaldi, M. Pepa, M. Amadori, P. Antognoni, S. Arcangeli, A. Buffoli, G. Beltramo, S. Berlinghieri, M. Bignardi, S. Bracelli, L. Bruschieri, S. Castiglioni, G. Catalano, N. Di Muzio, C. Fallai, L. Fariselli, A.R. Filippi, A. Gramaglia, C. Italia, F. Lombardi, S.M. Magrini, S. Nava, E. Orlandi, N. Pasinetti, E.L. Sbicego, L. Scandolaro, M. Scorsetti, F. Stiglich, S. Tonoli, R. Tortini, R. Valdagni, V. Vavassori, G. Marvaso
Radiotherapy treatment volumes for oligorecurrent nodal prostate cancer: a systematic review
2020 V. Achard, M. Bottero, M. Rouzaud, A. Lancia, M. Scorsetti, A.R. Filippi, C. Franzese, B.A. Jereczek-Fossa, G. Ingrosso, P. Ost, T. Zilli
Oligometastasis and local ablation in the era of systemic targeted and immunotherapy
2020 R. Mazzola, B.A. Jereczek-Fossa, D. Franceschini, S. Tubin, A.R. Filippi, M. Tolia, A. Lancia, G. Minniti, S. Corradini, S. Arcangeli, M. Scorsetti, F. Alongi
Letter to the Editor regarding ESTRO-ASTRO guidelines on lung cancer radiotherapy during COVID-19 pandemic
2020 S.M. Magrini, P. Borghetti, A.R. Filippi, M. Scorsetti, B.A. Jereczek-Fossa, R. Corvo, S. Arcangeli, S. Vagge, E. Russi, F. Alongi, L. Livi, M. Buglione
COVID-19 outbreak and cancer radiotherapy disruption in Italy : Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
2020 B.A. Jereczek-Fossa, M. Pepa, G. Marvaso, A. Bruni, M. Buglione di Monale e Bastia, G. Catalano, A.R. Filippi, P. Franco, M.A. Gambacorta, D. Genovesi, G. Iatì, A. Magli, L. Marafioti, I. Meattini, A. Merlotti, M. Mignogna, D. Musio, R. Pacelli, S. Pergolizzi, V. Tombolini, M. Trovò, U. Ricardi, S.M. Magrini, R. Corvò, V. Donato